Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GEMOXIAL: Adjuvant Chemotherapy for HCC
NCT00470340Phase 3Terminated
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jun 2007
- Primary completion
- Nov 2008
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 3 trial of cisplatin, gemcitabine, oxaliplatin in hepatocellular carcinoma (HCC), sponsored by Assistance publique - Hôpitaux de Paris. Started Jun 2007; status: terminated.
02
Drugs
cisplatingemcitabineoxaliplatin
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT00470340.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00470340.